4
Changes in Ownership
Apimeds Pharmaceuticals US, Inc. Filed Acc 0001474506-25-000100
Chairman and CMO acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kim Christopher Chairman and CMO | 2025-05-16 | Grant or award | +250,000 | 277,500 | D |
Loading xslF345X05/primary_doc.xml…